BIPIX ProFunds Biotechnology UltraSector Inv Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Arrowhead Pharmaceuticals (NASDAQ:ARWR).

The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the S&P Biotechnology Select Industry Index. The index is designed to measure the performance of biotechnology companies included in the S&P Total Market Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

The average market capitalization across the ProFunds Biotechnology UltraSector Inv MF is 12.66B. The market cap for tickers in the group ranges from 5.25B to 45.31B. RVMD holds the highest valuation in this group at 45.31B. The lowest valued company is APLS at 5.25B.

The average weekly volume growth across all stocks in the ProFunds Biotechnology UltraSector Inv MF was 33%. For the same stocks of the MF, the average monthly volume growth was 32% and the average quarterly volume growth was -43%